Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
the issue of access to drugs has shifted from anti aids drugs in Africa to anti anthrax drugs in the us. The us government is contemplating to override the patent on Ciprofloxacin, which is held by the German pharmaceutical company, Bayer and procure generic copies from other sources. This move …
In a landmark judgement, a Japanese court has found a former top official in the health ministry guilty of supplying blood contaminated by HIV. The case is said to be significant by many experts as Japanese bureaucrats are rarely punished for inaction. The Tokyo district court handed down a one-year …
The Brazilian government is planning to declare aids a national emergency. The country's health minister, Jose Serra, said the decision was made after negotiations to lower the price of nelfinavir, an aids drug manufactured by Hoffman-La Roche Incorporation, recently failed. The action is being taken under a legislation that permits …
anti-hiv drugs could be useless for nearly half of patients within four years, according to a computer model prediction. The new study, using data from the San Francisco, usa- based gay community, suggests that by 2005, at least 42 per cent of hiv cases could be drug resistant. In 1997, …
AIDS activists are suing the South African government for its failure to distribute an anti-HIV drugs that could save the lives of about 35,000 newborn babies each year. The lawsuit will be filed by the Treatment Action Campaign (TAC), which played a leading role earlier this year in forcing multinational …
Developing nations prioritise expenditure and social costs, like that for pubic health, are the first to be axed. The Human Development Report 2001 indexes the overall development by including the expenditure made on health related activities. Developing countries, specially India, come out culprits for ignoring the health of its citizens. …
Starting September 1, 2001, Nigeria will launch the largest aids treatment programme in Africa using cheap generic drugs. The programme will cover 10,000 adults and 5,000 children. "It is quite an extraordinary intervention. It is aimed at the containment of the disease,' said Stephen Lewis, a un official.
pharmaceutical giant Cipla has introduced a three-in-one aids drug called Triomune. The new drug is a combination of stavudine, lamivudine and nevirapine. Cipla could synthesise the drug because Indian laws allow generic copies to be made. The generic drug would remain one of its kind, as the patent holders of …
The global pharmaceutical industry is feeling the heat. Following the industry's embarrassing withdrawal in April from a case against the South African government over the issue of access to cheap aids drugs, the us government dropped its complaint against Brazil's law dealing with the same issue at the World Trade …
The Mynmar government is falsifying statistics on AIDS cases to cover the fact that the disease has reached epidemic levels, alleges a us expert on AIDS. Chris Beyrer, an epidemiologist at the Johns Hopkins School of Hygiene and Public Health, says that 3.46 per cent of adults in Mynmar are …
Africa's first consignment of cheap generic antiretroviral drugs for treating AIDS was given to Kenya's Nyumbani Orphanage on June 12, 2001. "It's the beginning of the flow of medicines that have hitherto been prohibited,' said Angelo D'Agostino, a priest who runs the orphanage. Five-year-old Dickson, made history by becoming the …
The Kenya Coalition for Access to Essential Medicines, a representative of all non-governmental organisations of the country, is putting pressure on the parliament to pass the Industrial Property Bill. This bill would allow the country to buy drugs at cheaper prices. Kenya's pharmaceutical industry has refused to sell life-saving drugs …
in the face of mounting pressure, pharmaceutical manufacturers have abandoned their challenge against the South African Government over the pricing of aids medication. After more than 24 hours of final negotiations, the pharmaceutical companies and the South African Government reached agreement. The withdrawal paves the way to the production and …
while battles rage between pharmaceutical companies and developing nations for cheaper access to existing drugs against aids, new research is also emerging. Two of the recent developments, one a vaccine that inhibits hiv, other, a therapy that attacks the deadly virus are worth the metion. A vaccine that does not …
Unlike sub-Saharan African countries, Brazil will not get discounts on two Acquired Immuno Deficiency Syndrome (aids) drugs that us-based Merck and Co Incorporation is planning to offer. "The discount on crixivan and stocrin is not applicable to Brazil,' said Marcos Levy, director of corporate affairs at Merck's Brazil unit. Responding …
cipla Limited of Mumbai has invited the wrath of multinationals companies (mncs) for offering to sell aids drugs at a cheap prices. The company proposes to sell the medicines to non-government organisations and doctors who would then distribute it in South Africa, where aids cases are high. The lowest price …
More than 40 pharmaceutical companies, including the world's largest and most powerful ones, will file a lawsuit against the South African government in a bid to stop it from passing a legislation aimed at reducing the price of medicines. The companies had tried to stop the South African parliament from …
A molecule traced recently might help in preventing the Acquired Immuno Deficiency Syndrome (AIDS) infection. Yvette van Kooyk of the University of Nijmegen, the Netherlands, along with her team, discovered the molecule. The molecule is found on cells with finger like projections that lie just beneath the skin and on …
In the last seven years, the number of Acquired Immuno Deficiency Syndrome (AIDS) cases in Bhutan has increased to fifteen. For a small country like Bhutan the number is considered to be a cause of grave concern. "Bhutan is fortunate that a national AIDS strategy was introduced even before the …
